C12Y 207/11031
[hydroxymethylglutaryl-coa reductase ] kinase
Official title: [Hydroxymethylglutaryl-CoA reductase (NADPH)] kinase (2.7.11.31)
C12Y207/11031 ([hydroxymethylglutaryl-coa reductase ] kinase) appears on 4 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 10
- Assignees
- 13
- Inventors
- 36
- Latest grant
- 2 Mar 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 2 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Fluorescent AMP-kinase biosensors2 Mar 2021US 10,935,546 B2European Molecular Biology Laboratory
- One class of pyrazolone compounds and use thereof5 Feb 2019US 10,196,389 B2Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- AMPK activator screening method, and AMPK activator9 Jan 2018US 9,863,955 B2Kyorin Pharmaceutical Co., Ltd.
- 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them9 Aug 2016US 9,409,884 B2Rigel Pharmaceuticals, Inc.
- Methods and compositions to increase lifespan and healthspan by mimicking the effects of time-restricted feeding4 Jan 2024US 2024/0000753 A1The Trustees of Columbia University in the City of New York
- Compositions and methods for regulating t cells7 Dec 2023US 2023/0392117 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Rnai-based targeting compounds and uses thereof to prevent acquired hearing loss26 Jan 2023US 2023/0022117 A1MUSC Foundation for Research Development
- Methods of promoting cellular maturation with ampk activators19 May 2022US 2022/0152117 A1University of Washington
- Usp10 modulation of ampk and mtor31 Jan 2019US 2019/0030139 A1Mayo Foundation for Medical Education and Research
Most cited
By later US patents